A dangerous deal. An interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the government concluded with the United States under Donald Trump last December
A dangerous dealAn interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the government concluded with the United States under Donald…
Read the full articleYou might also wanna read
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
The NHS will divert billions of pounds from essential services to pay for new medicines under the terms of the US-UK trade deal agreed last
theguardian.com·6d ago
Analysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·8d agoAnalysis: UK-US trade deal could lead to 229,000 excess NHS deaths and £45bn in diverted funds
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·8d agoAnalysis: UK-US trade deal could force NHS to divert £45bn, causing 229,000 excess deaths in England
Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
theguardian.com·8d ago
Burnham urged to ditch ‘dangerous’ UK-US NHS drug deal
Exclusive: health groups call on expected next prime minister to rip up agreement, which analysis suggests could lead to 229,000 excess deat
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·7d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade
bmj.com·7d ago
Starmer's US pharma deal criticized as costly threat to NHS and public health
The deal on medicine imports will cost the NHS billions and take funding away from doctors, nurses, cancer scans and the rest, says Guardian
theguardian.com·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.